Abstract
OBJECTIVE:
This study compared the effect of the angiotensin-converting enzyme (ACE) insertion/deletion (I/D) polymorphisms on the incidence and outcome of sepsis in ventilated very low birth weight infants.
STUDY DESIGN:
Infectious complications were retrospectively determined in 295 (234 African-American, 58 Caucasian and three Hispanic) mechanically ventilated very low birth weight (VLBW) infants (<1500 g at birth) and compared ACE I/D genotype.
RESULTS:
The incidence of the D allele in the study population was 0.60. A total of 113 (38.3%) infants were homozygous DD, 128 (43.4%) were heterozygous ID and 54 (18.3%) were homozygous II. One or more episodes of late BSI developed in 28 (52%) of 54 infants with the II genotype, 66 (52%) of 128 infants with the ID genotype and 52 (46%) of 113 infants with the DD genotype (p=0.618). Neither the rates of non-CONS BSI (II: 24%, ID: 23%, DD: 22%; p=0.937) nor multiple bacteremic/fungemic episodes (II: 13%, ID: 16%, DD: 12%; p=0.641) were different between genotype groups. The ACE I/D polymorphism had no effect on sepsis-related mortality (II: 7%, ID: 5%, DD: 4%; p=0.692). Sepsis mortality for infants with late BSI was 14% in infants with the II genotype, 9% with the ID genotype and 10% with the DD genotype (p=0.764).
CONCLUSIONS:
The ACE I/D polymorphism does not have a significant effect on the incidence or outcome of sepsis in ventilated VLBW infants.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Makhoul IR, Sujov P, Smolkin T, Lusky A, Reichman B . Epidemiological, clinical, and microbiological characteristics of late-onset sepsis among very low birth weight infants in Israel: a national survey. Pediatrics 2002;109(1):34–39.
Baier RJ, Bocchini Jr JA, Brown EG . Selective use of vancomycin to prevent coagulase-negative staphylococcal nosocomial bactermeia in high risk very low birth weight infants. Pediatr Infect Dis 1998;17:179–183.
Tseng YC, Chiu YC, Wang JH, Lin HC, Su BH, Chiu HH . Nosocomial bloodstream infection in a neonatal intensive care unit of a medical center: a three-year review. J Microbiol Immunol Infect 2002;35(3):168–172.
Stoll BJ, Hansen N, Fanaroff AA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002;110(2):285–291.
Hotchkiss RS, Karl IE . The pathophysiology and treatment of sepsis. N Engl J Med 2003;348(2):138–150.
Lazarus DS, Aschoff J, Fanburg BL, Lanzillo JJ . Angiotensin converting enzyme (kininase II) mRNA production and enzymatic activity in human peripheral blood monocytes are induced by GM-CSF but not by other cytokines. Biochim Biophys Acta 1994;1226(1):12–18.
Nakamura A, Johns EJ, Imaizumi A, Yanagawa Y, Kohsaka T . Effect of beta(2)-adrenoceptor activation and angiotensin II on tumour necrosis factor and interleukin 6 gene transcription in the rat renal resident macrophage cells. Cytokine 1999;11(10):759–765.
Constantinescu CS, Goodman DBP, Ventura ES . Captopril and lisinopril supress production of interleukin-12 by human peripheral blood mononuclear cells. Immunol Lett 1998;62:25–31.
Phillips MI, Kagiyama S . Angiotensin II as a pro-inflammatory mediator. Curr Opin Investig Drugs 2002;3(4):569–577.
Ito H, Takemori K, Suzuki T . Role of angiotensin II type 1 receptor in the leucocytes and endothelial cells of brain microvessels in the pathogenesis of hypertensive cerebral injury. J Hypertens 2001;19(3 Part 2):591–597.
Takeuchi M, Nakada H, Nagai S . [Expression of angiotensin II receptor on BALF macrophages from patients with sarcoidosis and healthy individuals]. Nihon Kyobu Shikkan Gakkai Zasshi 1992;30(Suppl):213–218.
Rice CL, Kohler JP, Casey L, Szidon JP, Daise M, Moss GS . Angiotensin-converting enzyme (ACE) in sepsis. Circ Shock 1983;11(1):59–63.
Casey L, Krieger B, Kohler J, Rice C, Oparil S, Szidon P . Decreased serum angiotensin converting enzyme in adult respiratory distress syndrome associated with sepsis: a preliminary report. Crit Care Med 1981;9(9):651–654.
Watanabe K, Lam G, Keresztes RS, Jaffe EA . Lipopolysaccharides decrease angiotensin converting enzyme activity expressed by cultured human endothelial cells. J Cell Physiol 1992;150(2):433–439.
Tiret L, Rigat B, Visvikis S, et al. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992;51(1):197–205.
Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F . An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86(4):1343–1346.
Morimoto S, Okaishi K, Onishi M, et al. Deletion allele of the angiotensin-converting enzyme gene as a risk factor for pneumonia in elderly patients. Am J Med 2002;112(2):89–94.
Harding D, Baines PB, Brull D, et al. Severity of meningococcal disease in children and the angiotensin-converting enzyme insertion/deletion polymorphism. Am J Respir Crit Care Med 2002;165:1103–1106.
Baier RJ, Loggins J, Kruger TE . Increased interleukin-8 and monocyte chemoattractant protein-1 concentrations in mechanically ventilated preterm infants with pulmonary hemorrhage. Pediatr Pulmonol 2002;34(2):131–137.
Baier RJ, Loggins J, Kruger TE . Monocyte chemoattractant protein-1 and interleukin-8 are increased in bronchopulmonary dysplasia: relation to isolation of Ureaplasma urealyticum. J Investig Med 2001;49(4):362–369.
Asamoah A, Yanamandra K, Thurmon TF, et al. A deletion in the angiotensin converting enzyme (ACE) gene is common among African Americans with essential hypertension. Clin Chim Acta 1996;254(1):41–46.
Cho SJ, Lee SJ . ACE gene polymorphism and renal scar in children with acute pyelonephritis. Pediatr Nephrol 2002;17(7):491–495.
Bloem LJ, Manatunga AK, Pratt JH . Racial difference in the relationship of an angiotensin I-converting enzyme gene polymorphism to serum angiotensin I-converting enzyme activity. Hypertension 1996;27(1):62–66.
Hedberg CL, Adcock K, Martin J, Loggins J, Kruger TE, Baier RJ . Tumor necrosis factor alpha −308 polymorphism associated with increased sepsis mortality in ventilated very low birth weight infants. Pediatr Infect Dis J 2004;23(5):424–428.
Ahrens P, Kattner E, Kohler B, et al. Mutations of genes involved in the innate immune system as predictors of sepsis in very low birth weight infants. Pediatr Res 2004;55(4):652–656.
Harding D, Dhamrait S, Millar A, et al. Is interleukin-6 −174 genotype associated with the development of septicemia in preterm infants? Pediatrics 2003;112(4):800–803.
Stoll B, Hansen N, Fanaroff AA, et al. Changes in pathogens causing early-onset sepsis in very low birth weight infants. N Eng J Med 2002;347:240–247.
Acknowledgements
The authors gratefully acknowledge the expert technical assistance of Dawn Napper in performance of this investigation.
Author information
Authors and Affiliations
Additional information
Presented in part at the Society for Pediatric Research Annual meeting May 2004 San Francisco, CA.
Rights and permissions
About this article
Cite this article
John Baier, R., Loggins, J. & Yanamandra, K. Angiotensin Converting Enzyme Insertion/Deletion Polymorphism Does Not Alter Sepsis Outcome in Ventilated Very Low Birth Weight infants. J Perinatol 25, 205–209 (2005). https://doi.org/10.1038/sj.jp.7211231
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jp.7211231